[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Yagi et al., 2016 - Google Patents

Diagnostic accuracy of neuropsychological tests for classification of dementia.

Yagi et al., 2016

Document ID
10922256581783797791
Author
Yagi T
Ito D
Sugiyama D
Iwasawa S
Tabuchi H
Konishi M
Araki M
Saitoh N
Nihei Y
Mimura M
Suzuki N
Publication year
Publication venue
Neurology Asia

External Links

Snippet

Although numerous studies have shown that each neuropsychological test is effective for diagnosing mild cognitive impairment (MCI) or Alzheimer's disease (AD), studies comparing diagnostic accuracies of various neuropsychological tests are relatively rare and practical …
Continue reading at search.ebscohost.com (other versions)

Classifications

    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/345Medical expert systems, neural networks or other automated diagnosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06QDATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10Services
    • G06Q50/22Health care, e.g. hospitals; Social work
    • G06Q50/24Patient record management

Similar Documents

Publication Publication Date Title
Milani et al. Optimal cutoffs for the Montreal Cognitive Assessment vary by race and ethnicity
Bondi et al. Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates
Rascovsky et al. Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and AD
Wallin et al. The Gothenburg MCI study: design and distribution of Alzheimer’s disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up
Freitas et al. Montreal Cognitive Assessment (MoCA): validation study for frontotemporal dementia
Lin et al. Insula and inferior frontal gyrus’ activities protect memory performance against Alzheimer’s disease pathology in old age
Gallagher et al. Mild cognitive impairment, screening, and patient perceptions in heart failure patients
Bartos et al. Validation of the czech montreal cognitive assessment for mild cognitive impairment due to Alzheimer disease and czech norms in 1,552 elderly persons
Ueki et al. Factors associated with mortality in patients with early‐onset Alzheimer's disease: a five‐year longitudinal study
Naik et al. Diagnosing dementia‐ICD‐10 not so bad after all: a comparison between dementia criteria according to DSM‐IV and ICD‐10
Roy et al. Preliminary investigation of cognitive function in aged multiple sclerosis patients: challenges in detecting comorbid Alzheimer’s disease
Wood et al. Montreal Cognitive Assessment (MoCA) performance and domain-specific index scores in amnestic versus aphasic dementia
Hsiao et al. Longitudinal declines in instrumental activities of daily living in stable and progressive mild cognitive impairment
Devlin et al. Heterogeneity of neuropsychological impairment in HIV infection: contributions from mild cognitive impairment
Yagi et al. Diagnostic accuracy of neuropsychological tests for classification of dementia.
desRosiers et al. The neuropsychological differentiation of patients with very mild Alzheimer's disease and/or major depression
Rosca et al. Montreal cognitive assessment for evaluating cognitive impairment in Huntington’s disease: A systematic review
Shim et al. Literacy independent cognitive assessment: assessing mild cognitive impairment in older adults with low literacy skills
Thomas et al. Olfactory impairment in mild cognitive impairment with Lewy bodies and Alzheimer’s disease
Darby et al. Episodic memory decline predicts cortical amyloid status in community-dwelling older adults
Hicks et al. Associations of visual paired associative learning task with global cognition and its potential usefulness as a screening tool for Alzheimer’s dementia
Seubert-Ravelo et al. Mild cognitive impairment in patients with early-onset Parkinson's disease
Eliassen et al. Predictive and diagnostic utility of brief neuropsychological assessment in detecting Alzheimer’s pathology and progression to dementia.
Vogel et al. Frequency and severity of semantic deficits in a consecutive memory clinic cohort
Younes et al. Internet-based cognitive testing in multiple sclerosis